cyclosporine has been researched along with Common Bile Duct Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araya, H; Hayashi, M; Tomita, M | 1 |
| Deters, M; Kaever, V; Kirchner, G; Klabunde, T; Resch, K | 1 |
2 other study(ies) available for cyclosporine and Common Bile Duct Diseases
| Article | Year |
|---|---|
The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion II: stable gastrointestinal absorption of a poorly water soluble new compound, ER-1258 in bile-fistula rats.
Topics: Animals; Area Under Curve; Bile; Biliary Fistula; Common Bile Duct Diseases; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Design; Emulsions; Estrogen Receptor Modulators; Intestinal Absorption; Male; Rats; Rats, Sprague-Dawley; Solubility; Surface-Active Agents | 2005 |
Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Fistula; Bilirubin; Body Weight; Cholagogues and Choleretics; Cholesterol; Common Bile Duct Diseases; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Sirolimus; Tacrolimus; Triglycerides | 2002 |